A federal appeals court in Washington revived a lawsuit brought against AstraZeneca, Pfizer, Johnson & Johnson, and other medical supply and manufacturing companies by victims of attacks perpetrated by the terrorist group Jaysh al-Mahdi. The plaintiffs claim the defendants assisted the group through the “corrupt provision of free goods and cash bribes” to do business with Iraq’s Ministry of Health that was, at the time, allegedly “overrun” by the terrorists.
Read the opinion here .
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Search Articles
